Two Sigma Investments’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2K Sell
13,279
-19,757
-60% -$33.8K ﹤0.01% 4504
2025
Q4
$63.8K Buy
+33,036
New +$65.9K ﹤0.01% 3907
2022
Q1
Sell
-12,927
Closed -$310K 3044
2021
Q4
$310K Buy
12,927
+11,865
+1,117% +$244K ﹤0.01% 3623
2021
Q3
$21K Buy
+1,062
New +$20.9K ﹤0.01% 4167
2021
Q1
Sell
-2,433
Closed -$39K 3894
2020
Q4
$39K Buy
+2,433
New +$34.1K ﹤0.01% 3260

Other funds holding DARE

Two Sigma Investments's DARE Position: Q1 2026 in Review

Two Sigma Investments reduced its Dare Bioscience (DARE) stake by 60% in Q1 2026, selling an estimated $33.8K and leaving 13,279 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4504.

Two Sigma Investments first reported a position in DARE in Q4 2020 and has held it in 5 quarters since. The position peaked at $310K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • Two Sigma Investments held 13,279 shares of Dare Bioscience worth $24.2K as of Q1 2026.
  • Two Sigma Investments sold 19,757 Dare Bioscience shares in Q1 2026, an estimated $33.8K.
  • Dare Bioscience made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #4504 holding.
  • Two Sigma Investments first reported a position in Dare Bioscience in Q4 2020 and has held it in 5 quarters since.
  • Two Sigma Investments's Dare Bioscience position peaked at $310K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.